Editorial: The changing landscape of cystic fibrosis: new therapies, challenges and a global pandemic

2020 ◽  
Vol 26 (6) ◽  
pp. 668-670
Author(s):  
Peter J. Barry ◽  
Barry J. Plant
Keyword(s):  
Cystic Fibrosis ◽  
New Therapies ◽  
Global Pandemic

scholarly journals Increase of survival and improvement of the prognosis with new therapies for the treatment of cystic fibrosis

2018 ◽  
Vol 61 ◽  
pp. e393
Author(s):  
M.J. Buzzetta Devis ◽  
M.E. Martinez Rodriguez ◽  
A. Lamas Ferrero ◽  
J.C. Estupiñan ◽  
D. Pozo Crespo ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
New Therapies

Non-cystic fibrosis bronchiectasis: an evidence-base for new therapies

2014 ◽  
Vol 2 (12) ◽  
pp. 958-960 ◽  
Author(s):  
Diana Bilton ◽  
Michael R Loebinger ◽  
Robert Wilson
Keyword(s):  
Cystic Fibrosis ◽  
Evidence Base ◽  
New Therapies

scholarly journals Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis

2011 ◽  
Vol 32 (6) ◽  
pp. 693-701 ◽  
Author(s):  
Zhi-wei Cai ◽  
Jia Liu ◽  
Hong-yu Li ◽  
David N Sheppard
Keyword(s):  
Cystic Fibrosis ◽  
New Therapies

scholarly journals Pancreatitis in A Patient with Cystic Fibrosis Taking Ivacaftor

Children ◽  
2020 ◽  
Vol 7 (1) ◽  
pp. 6 ◽  
Author(s):  
Argyri Petrocheilou ◽  
Athanasios G. Kaditis ◽  
Ioanna Loukou
Keyword(s):  
Cystic Fibrosis ◽  
Pancreatic Insufficiency ◽  
Cystic Fibrosis Transmembrane Regulator ◽  
Pancreatic Exocrine Function ◽  
Exocrine Function ◽  
Partial Recovery ◽  
New Therapies ◽  
Pancreatic Exocrine ◽  
Cystic Fibrosis Transmembrane ◽  
Cftr Modulators

Pancreatitis is rare in pancreatic insufficient cystic fibrosis patients. While pancreatic insufficiency has been considered irreversible until now, in the current era of new therapies with modulators of the Cystic Fibrosis Transmembrane Regulator CFTR channel, there are reports of improvement of pancreatic exocrine function. We describe the case of an adolescent with cystic fibrosis who developed pancreatitis after the partial recovery of pancreatic function while taking ivacaftor. This case adds to the limited body of evidence that CFTR modulators lead to the improvement of pancreatic exocrine function in cystic fibrosis.

New Therapies in Cystic Fibrosis

2012 ◽  
Vol 18 (5) ◽  
pp. 614-627 ◽  
Author(s):  
Felix Ratjen ◽  
Hartmut Grasemann
Keyword(s):  
Cystic Fibrosis ◽  
New Therapies

scholarly journals Pediatric population with cystic fibrosis in the centre of Portugal: Candidates for new therapies

2021 ◽  
Author(s):  
Juliana Roda ◽  
Teresa Teixeira ◽  
Iris AI Silva ◽  
Teresa Reis Silva ◽  
Ricardo Ferreira ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Pediatric Population ◽  
New Therapies

Primary ciliary dyskinesia: prospects for new therapies, building on the experience in cystic fibrosis

2009 ◽  
Vol 10 (2) ◽  
pp. 58-62 ◽  
Author(s):  
Israel Amirav ◽  
Malena Cohen-Cymberknoh ◽  
David Shoseyov ◽  
Eitan Kerem
Keyword(s):  
Cystic Fibrosis ◽  
Primary Ciliary Dyskinesia ◽  
New Therapies ◽  
Ciliary Dyskinesia
Sign in / Sign up

Export Citation Format

Share Document